Please provide your email address to receive an email when new articles are posted on . Carl Zeiss Meditec and Precise Bio have partnered to develop and commercialize fabricated corneal tissue for ...
Carl Zeiss Meditec will invest in Precise Bio and fund the further development of Precise Bio's two cornea transplant products and has exclusive worldwide commercialization rights for these products ...
Ophthalmic and microsurgery device maker Carl Zeiss Meditec AG is investing in regenerative medicine startup Precise Bio Ltd. to jointly develop 4D bio-fabricated corneal transplants for diseases that ...
Carl Zeiss Meditec is a high-quality MedTech company with a strong market position, low debt, and significant long-term upside potential despite current macroeconomic challenges. The company's ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback